Medicaid and Health Choice Preferred Drug List Changes

Effective with a date of service of May 17th, 2014, the N.C. Division of Medical Assistance (DMA) made changes to the N.C. Medicaid and N.C. Health Choice Preferred Drug List (PDL). Below are highlights of some of the changes:

- The prior authorization criteria was removed from the second generation anti-convulsant class
- The use of only Spiriva® in the COPD class is required before moving to a non-preferred agent
- Adderall XR and Adderall generics were removed from the PDL entirely. Prior authorization is required for these generic products
- New classes were added: Under CARDIOVASCULAR, Sympatholytics and Combinations, under ENDOCRINOLOGY, Sodium Glucose Co-Transporter 2 (SGLT2), under OPHTHALMIC, Antibiotics-Steroid Combinations, under OTIC, Anti-Infectives and Anesthetics, under TOPICALS, Antibiotics-Vaginal, and under MISCELLANEOUS, Estrogen Agent Combinations and Estrogen Agent Oral/Transdermal

In addition to the changes above, the preferred brands with non-preferred generic equivalents were updated and are listed in the chart below: